Study defines stem cell groups that drive myelodysplastic syndromes, finds potential targeted therapy option
Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified possible ...
Mar 3, 2022
0
53